Cardiff Lexington Corp (CDIX) — SEC Financial Statements & Analysis

Cardiff Lexington Corp (CDIX) is a services-offices & clinics of doctors of medicine company, incorporated in FL. Cardiff Lexington Corp trades on OTC as: CDIX. Cardiff Lexington Corp (CDIX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Cardiff Lexington Corp carries a market cap of $23.66M, a P/E ratio of -2.38x, a P/B ratio of 13.48x, a P/S ratio of 2.32x, an enterprise value of $44.89M, and an EV/EBITDA multiple of -40.57x. On profitability, it posts a gross margin of 60.42%, an operating margin of -10.86%, a net margin of -97.49%, a Return on Equity (ROE) of -793.72%, a Return on Assets (ROA) of -34.82%, and a Return on Invested Capital (ROIC) of -6.05%. Per share, it reports EPS of $-0.65, diluted EPS of $-0.65, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 0.31% year-over-year, net income growth of 125.58% year-over-year, and EPS growth of -8.51% year-over-year. On the balance sheet, it maintains a current ratio of 0.91x, a quick ratio of 0.90x, working capital of $-2.31M, a debt-to-equity ratio of 15.44x, a debt ratio of 0.88, an interest coverage ratio of -0.14x, free cash flow of $-1.63M (TTM), and net debt of $21.22M. Figures sourced from SEC EDGAR.

Market Cap

$23.66M

P/E TTM

-2.38x

EPS TTM

$-0.65

P/B TTM

13.48x

ROE TTM

-793.72%

ROA TTM

-34.82%

Debt To Equity

15.44x

Free Cash Flow TTM

$-1.63M

Net Revenue TTM Growth 1Y

0.31%

Data as of 2026-06-30 · Source: SEC EDGAR